Allopurinol hypersensitivity syndrome
Canadian Urological Association Journal · 2024-01-30 · 18 (5)
DOI: 10.5489/cuaj.8685 ↗At a glance
Übersichtsarbeit in Canadian Urological Association Journal, published online on 2024-01-30. Written by Tariq Alotaibi and 6 co-authors. Institution: Division of Urology, Department of Surgery, Schulich School of Medicine and Dentistry, London, ON, Canada. Cited 14 times so far (Crossref). The full text is freely available in PubMed Central.
Abstract (original language)
Allopurinol is a commonly prescribed agent in the urologic population for the prevention of urinary stones. Although generally well-tolerated, several serious potential side effects can occur with its use. Allopurinol hypersensitivity syndrome (AHS), in particular, is a relatively rare but potentially life-threatening complication. With the observed increase in urinary stone disease, especially those of uric acid composition, it is likely that the use of allopurinol will increase. Urologists play an important role in the assessment and medical management of patients with urinary stones, thus a greater awareness of the potential adverse events associated with allopurinol use, especially AHS, is important, as well as strategies that can minimize such risks. In this report we review the potential adverse effects of allopurinol. In addition, the results of a comprehensive review of the current literature on AHS will be presented, highlighting those patients at highest risk, reviewing the genetic susceptibility testing currently available, and providing guidance on best practices when allopurinol therapy is being considered.
Authors and institutions
- Division of Urology, Department of Surgery, Schulich School of Medicine and Dentistry, London, ON, Canada.
- Division of Clinical Pharmacology, Department of Medicine, Schulich School of Medicine and Dentistry, London, ON, Canada.
- Division of Nephrology, Department of Medicine, Schulich School of Medicine and Dentistry, London, ON, Canada.
Cite
APA
Alotaibi, T., Bjazevic, J., Kim, R., Gryn, S., Sultan, N., Dresser, G., & Razvi, H. (2024). Allopurinol hypersensitivity syndrome. Canadian Urological Association Journal, 18(5). https://doi.org/10.5489/cuaj.8685
Vancouver
Alotaibi T, Bjazevic J, Kim R, Gryn S, Sultan N, Dresser G, et al. Allopurinol hypersensitivity syndrome. Canadian Urological Association Journal. 2024;18(5). doi:10.5489/cuaj.8685
BibTeX
@article{Alotaibi2024,
author = {Alotaibi, Tariq and Bjazevic, Jennifer and Kim, Richard and Gryn, Steven and Sultan, Nabil and Dresser, George and Razvi, Hassan},
title = {Allopurinol hypersensitivity syndrome},
journal = {Canadian Urological Association Journal},
year = {2024},
volume = {18},
number = {5},
doi = {10.5489/cuaj.8685}
}
EUVIMED